NYSA TI Single-Page 3
Testimony of STANTON A. GLANTZ, Phl) Pro_.sor of Me_cine
Abstract
My name is Stanton A. Glantz. I hold a Ph.D. in Applied Mechanics and Engineering Economics fi'om Stanford University, where I wrote my dissertation on the mechanics of cardiac muscle. I am now a Professor of Medicine at the University of California, San Francisco in the Division of Cardiology and a member of the Cardiovascular Research Institute and the Institute for Health Policy Studies, as well as th~ Graduate Group in Biostatistics.
Fields
- Named Organization
- American Heart Association (Voluntary health organization that focuses on cardiac health)Voluntary health organization that focuses on cardiac health and stroke. AHA occasionally teams with tobacco retailers to engage in promotions/fund-raisers (see http://www.smokefree.net/doc-alert/messages/247136.html and http://www.rawbw.com/~jpk/stand/Pictures.html).
- Consumer Reports (magazine that tested tar content in 50s)
- *Department of Health and Human Services
- Environmental Protection Agency (EPA)
- Lancet
- Medical College of Virginia
- National Institute of Occupational Safety and Health
- Occupational Safety and Health Administration (Held hearings in 1994 to ban smoking in workplaces)
OSHA opened hearings in September 1994 on a proposal that amounts to a virtual ban on smoking in every workplace in the nation- Occupational Safety and Health Administration (OSHA)
- Office on Smoking and Health
Responsible for creating reports on the health effects of smoking. Created by the Public Health Service.- Research Council
- Seventh Day Adventists (religion that prohibits smoking. runs smoking cessation prog)
- Stanford University
- University of Auckland (In New Zealand)
- *University of California (use specific branch)
- University of California San Diego
- University of California San Francisco
- Consumer Reports (magazine that tested tar content in 50s)
- Named Person
- Alexander, H.M. (Researcher on Youth Smoking, Newcastle, New South Whales)
- Dose, Albert R.
- Glantz, Stanton A.
- Pierce, J. P.
Sales Administration - Dose, Albert R.
- Date Loaded
- 18 Jul 2005
- Box
- 8705
Document Images
(~ with what a smolrer receives on an ~ basis) amoum of trains in
cigarettes had no additi~mal effe~. In contrast, in nonsmokers smoking j~st two ciga~ttes
significantly increased platelet activity, to the point that it was not signifi_~ntly different
from a habitual smoker. This situation illnstrates the fact that the responses of nonsmokers
and smokers to the toxins in the cigarette smoke aze often quite different. Based on the
data from smoke~s, one would conclude that additional exposure had no effect, whereas
looking at the effect on nonsmokers leads to the conclusion that it has a major effect.
More important, the same investigator (32) measured platelet activity in smokers and
nonsmokers before and after they sat in a room for 20 minutes where cigarettes had been
smoked just before the experimental subjects sat in the room. Again, there was no
significant change in the platelet activity among the smokers, but a significant increase in
platelet sticldness was seen among the nonsmokers to the point that their platelet activation
was not discernably different from the smokers. These data, together with the results of
other human experiments (30,36-39), indicate that nonsmokers are much more sensitive to
secondhand smoke than smokers and that very low levels of ETS exposure can have major
impact on nonsmokers' platelet activity. It also appears that the process saturates at low
dbses: once'the.nonsmoker has been exposed to even a low dose of secondhand smoke, the
platelets are maximally activated much like that to of a habitual smoker so that additional
exposure does not increase the effect. These data also indicate that dose-based
extrapolations from smokers to nonsmokers using cigarette equivalents" will grossly
underestimate the risks to nonsmokers of breathing secondhand smoke.
data also support this conclusion. In our stu~es of the effects of passive
smoldng ¢m he.art disease, we have ~ that b~ time (another measme of platelet
a : vity) is sign camb' shortened more phteL ) in both
11
T102322214

and.rats (42) eaposed at even the lowest doses of secondhand smote, with no additioml
effects at higher doses.
At a b'mch~ level, studies of cigarette smoke extract on the effects of platelet
activity suggest that the tcains in the ¢i~ smoke increa~_se platelet activation factor by
interfering with the activity of the plasma enzyme platelet activating factor acetylhydrolase
-"
(PAF-AH) (43). PAF-AH reduces platelet activity by neutralizing platelet activating factor.
Because toxins in the cigarette smoke appear to reduce the effectiveness of PAF-AH in
neutralizing platelet activating factor, these toxins may contribute to an increase in platelet
activity. The nicotine in the smoke does not appear to be the active agent, but rather some
other as yet undefined element in the cigarette smoke (37,43). This biochemical result is
reinforced by clinical studies which find that smokers treated with nicotine patches show
f~wer changes in platelet activity than continuing smokers despite having similar nicotine
levels (44).
Atherosderosis
In addition to short term toxicity of cigarette smoke, there are long-term permanent
effects. In particular, smoking contributes the development of narrowing and blockage of
the coronary arteries (atherosclemsis). When someone has a heart attack, one or more of
the arteries delivering blood to the heart has become completely blocked and the flow of
blood - and hence oxygen - to the hear~ muscle stops. If this flow is not restored promptly,
the muscle dies, causing a so-called myocardial infarction. The situation can lead to
irregular heart beats (arrhythmias) which can also be fataL
The coronary arteries are blocked through a proce~ ~ in ~ ways to blockage
of a pipe in ~ p.~ The ~ of the ~ is fast ~ ¢Rher chemically
T102322215

hardezfing aud ~ lmown as a~. As the vessel mrro~ the ~s ~e
that it will become completely blocked and cau~ a heart attack, eithe~ through slow
due to plaque or, more ohen, a blood dot lodging in the small remaining opening. The
toxic chemicals in the cigare~ tte smoke, and particularly polyvyelic aromatic hydrocarbons
(PAHs), f~:ilitatv ~ pro~s~ both by d ~ama~n~_g the cells ~ the coronary arteries and
also by stimulating plaque growth through a process similar to that of a benign tumor.
In addition to their role in acute thrombus f~rmafion, platelets are also important in
the development of atherosderosis. Once then is damage to the arterial endothelium (that
is, the lining of the coronary arteries), either through mechanical or chemical factors,
platelets interact with or adhere to the arterial wall and initiate a sequence that leads to
formation of atherosclerotic plaque. Ifplatelet aggregation is increased because of exposure
to ETS, the chances of platelets building up at that endothelial injury site will b¢ increased.
Thus, in addition to contributing to short-term effects by increasing the likelihood of
thrombus formation, the effects of ETS on platelets also increase the chances that
endothelial injury will lead to arterial plaque formation and atherosclerosis.
ETS also plays a role in causing damage to the endothelium and initiating the
atherosclerotic process. Experiments in humans have indicated that ¢v~n short-term
exposur~ to ETS - like active smoking (45) - significantly increases the appearance of
anuclear endothelial cell carcasses in the blood of people exposed to ETS (or other tobacco
products) constituents (30). The appearance of these cell carcasses indicates damage to the
endothelium, which is the initiating step in the atherosclerofic p~ The appearance of
endothelial cells after passivv smoking i~ nonsmok~ aher just 20 ~tcs
a hospital waiting room, is almost as g~at as in ~ smoking in nWL~~
L~
T102322216

~es to the
~e ~j~ ~a ~d promote
~i~ smo~ bo~ ~o~ adol¢~n~ whose p~n~ ~o~ ~ ~o ~ .~
~r~ ~ pla~s wb¢m ~o~ ~ ~d ¢~bit l~r I¢~ of ~ (~¢d good
cholesterol) demi~ ~popmte~ ~ people bma~ d¢~ ~ ~¢r adj~ ~r g~der
~d s~. ~ ~ ~o ~m~s ~¢ ~ of de~Iop~ ~m~ he~ ~e.
~e Role of ~v~]ic ~mafic Hy~bo~ ~)
M~ a~emsdemdc pla~es
(46). ~r~
7,12-~Ib~m(~h)~ea~ ~) ~d ~(a)~a~ ~),
developmem of a~emsdems~ (47-51). ~ ~ m ~~t ~fiment of E~ (15~2).
Chmges
• ~ inj~ ~at loa~ to p~t¢let a~gafion ~d pl~u¢
Se~r~ s~s ~ ~di~ted ~at pol~c ~fic ~~m pm~mn~y.
co~e~
additio~
of ~olesteml, which m~ ~tate ~co~orafion of
d~g ~ a~d~c pm~sa.
T102322217

- Se~,ml eart~ ~ smdi~s de~monstrated that it was possx'bte to acce~ate ~
athe~sd~tic proce~ in experimental ~ (warious spedes of ~ and pig~om)
by injection of BAP and other related PAHs (49.50). In additioa, it was possible to extract
cancer-like cells from plaques, which cau then be transplauted to another ~imal and
produce similar cells (50). ."
In addition to ~ biochemical evidence examining the effects of specific components
in ETS on the development of atherosclerotic lesions at a cellular and molecular level, there
have been a series of animal experiments which demonstrated that short-term exposure to
environmental tobacco smoke dramatically increases the rate in which lipids are deposited
in arterial linings. This is the initial process in the development of athexosclerotic lesions.
We (40) exposed three groups of rabbits on a high cholesterol diet to ten weeks of
exposure to secondhand smoke from Marlboro cigarettes. (This rabbit model has been used
to study atherosclerosis since 1908 (13).) The animals were exposed to the secondhand
smoke six hours a day, five days a week for just ten weeks. One group was ¢xposod to
smoke at levels that would be observed in a smoky bar or the others were exposed to levels
about three times as high. The high dose group was exposed to pollution levels comparable
to thbse observed in a Mazda 626 with the windows rolled up at 4 cigarettes/hr being
smoked (53). With just ten weeks of exposure (a total of 300 hours), the fraction of
pulmonary artery and aorta covered with lipid deposits nearly doubled compared to control
rabbits who ate the same diet but were not exposed to ETS. This is a short term exl~sure,
even fvr a rabbit.
This effect appears to be directly due to elements in the cig ~arette smoke it~.lf, rather
than a nervous ~ to berg ezposed to the smoke ~ ~ have ~ the
T102322218

active smokers.) To ad&ress ~ question, w¢ (41) exposed rabbits in an ¢ape~cnt ~ar
to that just described to second-hand smoke but gave half the rabbits the tmta-blocking drug
Metropolol, which block~..s the effects of catecholamines. As expected, the anlm~i~ receiving
the drug developed fewer lipid deposits than those who w~re receiving a placebo (saline),
but this effect was independent of whether the rabbits were breathing secondhand smoke.
Therefore, the secondhand smoke effects on the development of atherosclerotic-like lesions
in the arteries was not mediated by the increased levels of catecholamines.
One criticism that might be raised of this study is that the rabbits were on a high
cholesterol diet (54). This experimental model of atherosclemsis, which has been used since
early in the century, requires the rabbits to have a high cholesterol diet in order to develop
any lesions within a reasonable length of time. Other investigators (55,56) used cockerels
(another standard animal model for studying atherosclemsis) exposed to secondhand smoke
showed similar increases in the amount of plaque developed in young cockerels (between
6 and 22 weeks old) who were exposed to secondhand smoke six hours a day, five days a
week for twelve weeks while on a low cholesterol diet. These chickens were exposed to
lower levels of secondhand smoke than the rabbits studied and were eating a normal, low
cholesterol, diet. While there was no difgereuce in the plaque incidence between the
cockerels breathing secondhand smoke and the cockerels breathiug clean air, there was a
significant acceleration in the ~ of these plaques, in a dose-dependent ~er in the
ETS-exposed bi~s. The ~gens in the smoke appear to be acting as a promoter to
facilitate the development of plaques, raflaer than i~itiate
that these,effects are due to the carbon mon~de in the smoke,
16
T102322219

Even so, exposure to secondhand smoke f~ a relatively brief time (con~sponding to
about 0.4% of their life span) si/gtificantly accelezated the development of pla~ues. It is
reasonable to conclude f~om these results that in tkis animal model, moderate exposure to
secondhand smok'~ for a brief pe~od in early life is sufficient to markedly accelerate the
development of atherosclemtic plaques. The exposure levels used in ~ experknents axe
comparable to those observed in many workplace and household environments.
The fact'that it is possible to/nduce atherosclerotic-like changes /n two different
species of experimental animals with only a few weeks' exposure to secondhand smoke
similar to that experienced by people in normal day to day life, is a very important finding
linking the epidemiological and biochemical evidence that passive smoking causes heart
disease. On one hand, the epidemiological studies show an increased risk of heart disease
on a population basis among people exposed to secondhand smoke. On the other hand,
there are biochemical studies showing that elements in the smoke, particularly BAP and the
other PAHs, can produce cellular changes that occur in atherosclemsis. The experimental
s/udies on rabbits and cockerels, which do not suffer from the potential confounding
variables in epidemiological studies, bridge this gap by showing that it is possible to induce
atherosdemsis in experimental animals with ETS. Finally, there are also dam in humans
showing that passive smokers have f~nificanfly thicker carotid artery walls (the artery in the
neck) than people who never were exposed to passive or active smoking, with a dose-
response relationship (58).
the animal ~ents.
These results are consistent with what ~ ,,~yald expect
The causal link between passive smoki~ and atherosclexosis
17
T102322220

Fr~ radicals in ETS and ig~hcmic dmna~_
As already discussed, ~ ~ s~ ~de~l~
m s~~d ~ ~¢fien~ ~ a ~mr ~o~ ~ dea~ ~ ~ h~
~ ~d ~o non-fa~ o~n~ ~ ~ ~~
new e~den~ ~at p~ smo~ ~e~ ~e out~ of ~ ~c ~nt ~ ~e he~
~u~ ~e ~W of ~ ra~. F~e r~ ~ ~y ~a~ ~gen p~u~ w~ch
~ e~mely deserve m ~e he~ m~de ~11 mmbr~e
ce~ (59,60). ~e r~ h~ been ~pfi~ted ~ ~r ~ ~ ~ he~ ~e~e.) By
dis~p~g ~e a~W of ~e ~mbr~es ~ ~e he~ m~de ~ ~e ~ ~y
~teffem ~ ~n~o~ of ~e he~ m~e. ~cy h~ ~en ~y ~fi~ted
d~g ~e he~ h ~ what h ~ ~ ~pe~on ~j~." ~~ion ~j~
when bl~ st~ fl~g m he~ m~e ~er it h~ ~en ~m~pt~. ~ ~e bl~
~ st~ped, ~e he~ m~le ~ de~ of ~ge~ a si~fion ~ ~e~ For ~ple,
a re~sion inj~ ~ oc~ when ~meone s~en a he~ a~
~e~), fog~d by ~a~ent ~ ~opl~ (fo~ ~e ~e~ o~n ~ a b~n) or
a clot-bus~g ~ag ~at ~solms ~e clot (t~mb~) bl~ ~e ~m~ ~e~.
Repe~ion ~j~ ~ ~o o~ when a patient h~ had o~n h~ ~ ~ ~ of
blood m ~e he~ ~ s~ ~en s~ ~
~ea he~ muscle ~ depfi~d of ~gen ~u~
the ~lls which s~e ~e radi~ ~ depleted.
~e ~ ~ n~y ~d ~ ~e ~R ~ it r~~ ~d ~d~ ~ no~
T102322221

Studies of humans aud several species of ~ indicate that low ezposums to
nicotine or othar cigarette .~moke constituents significantly worsen repeffusion injury. For
example, slowly infusing the nicotine of just one cigarette doubled the effect of the
reperfusion injury on heart muscle of dogs (61). "Ibis is so'low a dose of nicotine that it had
no effect on heart rote, blood pressure, shortening contraction of the heart muscle itself as
the heart beats, or other hemodynamic measures of cardiac function commonly affected by
nicotine in active and passive smokers. After an ischemic episode in which the blood supply
to a section of the heart was interrupted for fifteen minutes, the shortening of the nmscle
in the heart wall during repeffusion was reduced to 50% of the pre-ischemic values. When
the dog was exposed to the nicotine from just a single cigarette, the muscle lengthened to
only 25% of control values. Thus, exposure to a very low dose of nicotine doubled the
impact of the reperfusion injury. When the dog was given a free radical scavenger which
neutralized the free radicals due to the nicotine, this effect was obliterated.
The effects of free radicals induced by passive smoking have been explored at the
cellular level (62,63). Rats who were exposed to secondhand smoke from two cigarettes a
day for two months exhibited severely damaged mitochondrial function during reperfusion
injury, so that the ability of cardiac mitochondrial cells to convert c0cygen into ATP was
much more compromised during ~perfusion injury among rats exposed to these low doses
of secondhand smoke than among control rats This is another way in which the tc~dns in
the secondhand smoke can interfere with energy metabolism in the cell.
TI023~

control free radicals (64).
In addition, passive smoking by h~ sensitizes lung neutrophlt~ (65). As with
plate.lets, neutrop~ are an important element of the body's defenses ~ ~ction and
damage. Inappropriately activated neutrophils, howevei; release oxidants and these
elements can play a role in tissue damage in p~ssive smokers. In a group of passive smokers
exposed to just three hours of sidestream smoke, there w~re significant increases in the
circulating leukocyte counts and stimulated neutrophil migration. Like the other
respomes, the responses to the exposure to secondhand smoky were greater in nonsmokers
than in smokers, again suggesting that the biochemistry of ETS in passive smokers is
different than in active smokers, with the passive smokers being more sensitive to these
elements. Likewise, when hamsters were exposed to the ETS from six cigarette a day for
eight weeks, the activity of anti-cmidant enzymes in their lungs nearly doubled. These
enzymes are natural factors which act to reduce the activity of free radicals. This study
deals with neutrophils in the lungs, but it is reasonable to assume that the neutrophils
exhibit similar effects throughout the body, since they are transported by the blood.
Myo~rdial Infarction (Hev-rt Attack)
There are also direct animal data to show that secondhand smoke promotes more
tissue damage following myocardial infarction (heart attack). Dogs exposed to secondhand
smoke one hour daily for t~ days, then subjected to blockage of a coronary artery
developed myocardial infarctions (dead tissue) that were twice as lmge as those of control
dogs who breathed clean air (66).
T102322223
